nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abdominal-pelvic lymphoproliferative disease after lung transplantation
|
Hachem, R.R |
|
2003 |
22 |
1S |
p. S194- 1 p. |
artikel |
2 |
Abstract reviewers
|
|
|
2003 |
22 |
1S |
p. S3-S5 3 p. |
artikel |
3 |
Accuracy of exhaled nitric oxide (eNO) measurements for the diagnosis of chronic rejection (CR) after lung transplantation (LTx)
|
Verleden, G.M |
|
2003 |
22 |
1S |
p. S182-S183 2 p. |
artikel |
4 |
A community-based weight management program for cardiac transplant recipients: results of a pilot study
|
Salyer, J.J |
|
2003 |
22 |
1S |
p. S130-S131 2 p. |
artikel |
5 |
A comparison of the efficacy of standard versus intermittent dosing of Rabbitt Anti-Thymocyte Globulin (RATG) for induction of heart transplant recipients
|
Shimamoto, P.L |
|
2003 |
22 |
1S |
p. S123- 1 p. |
artikel |
6 |
Activation of the classic complement cascade sequence in patients undergoing lung transplantation with and without antithymocyte globulin induction: a comparative study
|
Pope-Harman, A |
|
2003 |
22 |
1S |
p. S120-S121 2 p. |
artikel |
7 |
Acute and short-term hemodynamic and clinical effect of sildenafil in pulmonary arterial hypertension
|
McGoon, M.D |
|
2003 |
22 |
1S |
p. S153- 1 p. |
artikel |
8 |
Adherence to self-monitoring protocols after lung transplant
|
Rea, J.B |
|
2003 |
22 |
1S |
p. S131- 1 p. |
artikel |
9 |
Advances in preclinical cardiac xenotransplantation
|
McGregor, C.G |
|
2003 |
22 |
1S |
p. S89- 1 p. |
artikel |
10 |
Aerosol cyclosporine provides dose dependent improvement in lung function after lung transplantation
|
Corcoran, T.E |
|
2003 |
22 |
1S |
p. S77- 1 p. |
artikel |
11 |
Aerosolized cyclosporine as an alternative immunosuppressant in post lung transplant lymphoproliferative disease
|
Gilbert, S |
|
2003 |
22 |
1S |
p. S185- 1 p. |
artikel |
12 |
Airborne transfer of pediatric patients on extracorporeal membrane oxygenator support
|
Fiser, W.P |
|
2003 |
22 |
1S |
p. S134- 1 p. |
artikel |
13 |
Air trapping in heart-lung transplant recipients: variability of anatomical distribution and extent on sequential expiratory thin-section CT
|
Bankier, A.A |
|
2003 |
22 |
1S |
p. S186-S187 2 p. |
artikel |
14 |
A longitudinal perspective on neurodevelomental outcome following infant cardiac transplantation
|
Freier, M.C. |
|
2003 |
22 |
1S |
p. S145- 1 p. |
artikel |
15 |
A new technique for assessing myocardial improvement using pressure-volume loops during mechanical circulatory assistance
|
Kadipasaoglu, K.A |
|
2003 |
22 |
1S |
p. S199- 1 p. |
artikel |
16 |
A novel selective inhibitor of jnk suppresses alloreactivity and prolongs cardiac allograft survival
|
Morikawa, M |
|
2003 |
22 |
1S |
p. S94- 1 p. |
artikel |
17 |
A novel sub-population of bone marrow derived myocardial stem cells: potential autologus cell therapy in myocardial infarction
|
Soukiasian, H.J |
|
2003 |
22 |
1S |
p. S79-S80 2 p. |
artikel |
18 |
Anti-CD25 antibody (BASILIXIMAB) therapy is not superior to anti-thymocyte globuline (ATG) for immunosuppression induction following heart transplantation
|
Fischer, S |
|
2003 |
22 |
1S |
p. S122- 1 p. |
artikel |
19 |
Antifungal management after lung transplantation (TX): a survey of 37 transplant centers
|
Dummer, S |
|
2003 |
22 |
1S |
p. S185- 1 p. |
artikel |
20 |
Apoptotic death of infiltrating cells in human cardiac allografts is regulated by IL-2
|
de Groot-Kruseman, H.A |
|
2003 |
22 |
1S |
p. S97- 1 p. |
artikel |
21 |
A retrospective analysis of 2 years experience using basiliximab (BMAB) in high risk lung transplant recipients(LTR) at a single institution
|
Levvey, B.J |
|
2003 |
22 |
1S |
p. S151- 1 p. |
artikel |
22 |
Are we listing the right children for heart transplant at the right time? Are we improving ?
|
OKeeffe, J.J |
|
2003 |
22 |
1S |
p. S176-S177 2 p. |
artikel |
23 |
A simple clinical predictive model for primary graft failure following lung transplantation
|
Christie, J.D |
|
2003 |
22 |
1S |
p. S160- 1 p. |
artikel |
24 |
Aspects of adherence to the treatment regimen following heart or heart-lung transplantation in young people
|
Wray, J.C |
|
2003 |
22 |
1S |
p. S130- 1 p. |
artikel |
25 |
Assessment of myocardial blood flow and coronary bypass graft patency during LVAD support
|
Maybaum, S |
|
2003 |
22 |
1S |
p. S211- 1 p. |
artikel |
26 |
Assessment of the phenotypic profile and T cell clonality in biopsies of lung allograft rejection
|
Pope-Harman, A |
|
2003 |
22 |
1S |
p. S137- 1 p. |
artikel |
27 |
Asthma donors are not a contraindication for lung transplantation(LTX): a 12 year single centre experience
|
Griffiths, A.P |
|
2003 |
22 |
1S |
p. S111-S112 2 p. |
artikel |
28 |
Atrioventricular orthotopic heart transplantation: long term follow up of a prospective randomised clinical trial
|
Jansz, P.C |
|
2003 |
22 |
1S |
p. S171- 1 p. |
artikel |
29 |
Autologous skeletal myoblasts transplanted to infarcted human myocardium: histological analysis of cell survival and differentiation
|
Pagani, F.D |
|
2003 |
22 |
1S |
p. S78-S79 2 p. |
artikel |
30 |
Autopsy Pathology (AP) in primate recipients of heterotopic xenografts (XG) functioning for >60 days
|
Tazelaar, H.D |
|
2003 |
22 |
1S |
p. S138- 1 p. |
artikel |
31 |
Azathioprine/Mycophenolate conversion in the management of Bronchiolitis Obliterans Syndrome (BOS) following (heart-)lung transplantation
|
Dupont, L.J |
|
2003 |
22 |
1S |
p. S123- 1 p. |
artikel |
32 |
Blockade of receptor for age (RAGE) suppresses T lymphocyte proliferation in mixed lymphocyte culture
|
Moser, B |
|
2003 |
22 |
1S |
p. S100- 1 p. |
artikel |
33 |
B-Natriuretic peptide improves hemodynamics and renal function in heart transplant patients immediately after surgery
|
Tann, S.M |
|
2003 |
22 |
1S |
p. S157- 1 p. |
artikel |
34 |
Bone marrow cell enhances the efficacy of skeletal myoblast transplantation in rats with ischemic cardiomyopathy
|
Sakaguchi, G |
|
2003 |
22 |
1S |
p. S79- 1 p. |
artikel |
35 |
Bone marrow inhibits allospecific T cell proliferation and clonal expansion
|
George, J.F |
|
2003 |
22 |
1S |
p. S104- 1 p. |
artikel |
36 |
Bone marrow mononuclear cell transplantation improved cardiac function of rat doxorubicin-induced cardiomyopathy model
|
Ishida, M |
|
2003 |
22 |
1S |
p. S124-S125 2 p. |
artikel |
37 |
Brain natriuretic peptide predicts rejection in heart transplant recipients independent of pulmonary capillary wedge pressure
|
Wu, A.H |
|
2003 |
22 |
1S |
p. S165- 1 p. |
artikel |
38 |
Bridge to cardiac transplantation: comparison of LVAD versus inotropic support
|
Moffatt, S.D |
|
2003 |
22 |
1S |
p. S207- 1 p. |
artikel |
39 |
Bridge to heart transplant with the continuos axial flow debakey VAD E
|
Lanfranconi, M |
|
2003 |
22 |
1S |
p. S204- 1 p. |
artikel |
40 |
Bronchiolitis obliterans syndrome/obliterative bronchiolitis ameliorated by azithromycin
|
Gerhardt, S.G |
|
2003 |
22 |
1S |
p. S78- 1 p. |
artikel |
41 |
Calcineurin-inhibitor-free immunosuppression with mycophenolatmofetil and sirolimus after cardiac transplantation is safe and improves renal function significantly
|
Groetzner, J |
|
2003 |
22 |
1S |
p. S150-S151 2 p. |
artikel |
42 |
Can changes over time in echocardiographic measurements; cardiopulmonary exercise testing and radionuclide ventriculography predict outcome in patients with chronic heart failure?
|
Stempfle, H.-U |
|
2003 |
22 |
1S |
p. S107- 1 p. |
artikel |
43 |
Cardiac angiotensin II receptors predict allograft vasculopathy in heart transplant recipients
|
Yousufuddin, M |
|
2003 |
22 |
1S |
p. S165- 1 p. |
artikel |
44 |
Cardiac pathology in porcine to primate heterotopic xenografts (XG) functioning for >60 days
|
Tazelaar, H.D |
|
2003 |
22 |
1S |
p. S137-S138 2 p. |
artikel |
45 |
Cardiac rhythm during and after explantation of left ventricular assist devices (LVAD) using the harefield recovery programme
|
Hardy, J |
|
2003 |
22 |
1S |
p. S202-S203 2 p. |
artikel |
46 |
Cardiac transplantation for the treatment of adults with congenital heart disease: a single center experience
|
Pinney, S.P |
|
2003 |
22 |
1S |
p. S179- 1 p. |
artikel |
47 |
Cardiac transplantation without prospective crossmatch in HLA-sensitized ventricular assist device patients
|
Etoch, S.W |
|
2003 |
22 |
1S |
p. S149- 1 p. |
artikel |
48 |
Cardiopulmonary bypass does not increase the morbidity associated with lung transplantation for chronic obstructive airway disease
|
Jansz, P.C |
|
2003 |
22 |
1S |
p. S190- 1 p. |
artikel |
49 |
Carvedilol in children with cardiomyopathy: 2 years follow up in a single institution
|
Rusconi, P |
|
2003 |
22 |
1S |
p. S135- 1 p. |
artikel |
50 |
Causes of death after heart transplantation and risk factor analysis
|
Angelini, A |
|
2003 |
22 |
1S |
p. S138-S139 2 p. |
artikel |
51 |
C4D as a diagnostic adjunct in lung allograft biopsies
|
Pope-Harman, A |
|
2003 |
22 |
1S |
p. S103- 1 p. |
artikel |
52 |
Cellular cardiomyoplasty using skeletal myoblasts overexpressing iL-1 receptor antagonist enhances effects on adverse post-infarction remodeling
|
Murtuza, B |
|
2003 |
22 |
1S |
p. S80- 1 p. |
artikel |
53 |
Cerebral hyperperfusion syndrome following LVAD implantation
|
Boyle, A.J |
|
2003 |
22 |
1S |
p. S203- 1 p. |
artikel |
54 |
Changes in collagen content of the myocardium by unloading with a cardiac assist device
|
Mueller, J |
|
2003 |
22 |
1S |
p. S195- 1 p. |
artikel |
55 |
Changes in the coronary artery adventitial microvascular density may be involved in the pathogenesis of coronary artery vasculopathy
|
Atkinson, C |
|
2003 |
22 |
1S |
p. S136- 1 p. |
artikel |
56 |
Characterization of regulatory CD8+CD28- T cells in heart transplant recipients
|
Colovai, A.I |
|
2003 |
22 |
1S |
p. S106- 1 p. |
artikel |
57 |
Chemokine receptor expression on BAL lymphocytes isolated from lung transplant recipients
|
Medoff, B.D |
|
2003 |
22 |
1S |
p. S100- 1 p. |
artikel |
58 |
Chronic therapy with the Acorn Cardiac Support Device normalizes gene expression of vascular endothelial and basic fibroblast growth factors in dogs with heart failure
|
Rastogi, S |
|
2003 |
22 |
1S |
p. S218- 1 p. |
artikel |
59 |
Chronotropic reserve beyond anerobic threshold (CRAT) predicts survival in advanced heart failure
|
Mehra, M.R |
|
2003 |
22 |
1S |
p. S86- 1 p. |
artikel |
60 |
Clinical predictors of improvement in ventricular function in non-ischemic dilated cardiomyopathy
|
Ahmed, S |
|
2003 |
22 |
1S |
p. S172- 1 p. |
artikel |
61 |
Clinical results with eptfe inflow conduit for mechanical circulatory support
|
Mussivand, T |
|
2003 |
22 |
1S |
p. S84- 1 p. |
artikel |
62 |
Clonally-expanded gamma-chain TCR transcripts are present in the coronary arteries of cardiac allografts from patients with chronic rejection
|
Jung, W.J |
|
2003 |
22 |
1S |
p. S105-S106 2 p. |
artikel |
63 |
Co-localisation of MMP-9 (gelatinase B) with airway neutrophils in stable lung transplant recipients-A potential role in the bronchiolitis obliterans syndrome
|
Forrest, I.A |
|
2003 |
22 |
1S |
p. S184- 1 p. |
artikel |
64 |
Combined prophylaxis of CMV-immune globulin plus ganciclovir versus CMV-immune globulin alone in high risk heart transplant recipients
|
Bonaros, N.E |
|
2003 |
22 |
1S |
p. S156- 1 p. |
artikel |
65 |
Comparison of quantitative PCR to antigenemia for CMV surveillance after lung transplantation
|
Cahill, B.C |
|
2003 |
22 |
1S |
p. S184- 1 p. |
artikel |
66 |
Comparison of survival by allocation to medical therapy, surgery or heart transplantation for ischaemic advanced heart failure
|
Lim, E |
|
2003 |
22 |
1S |
p. S166- 1 p. |
artikel |
67 |
Comparison of the calcium sensitizer levosimendan and prostaglandin E1 as a bridge to increased beta - blockade in patients with refractory, decompensated chronic heart failure
|
Berger, R |
|
2003 |
22 |
1S |
p. S110- 1 p. |
artikel |
68 |
Compliance behaviors of elderly patients with advanced heart failure
|
Evangelista, L.S |
|
2003 |
22 |
1S |
p. S127-S128 2 p. |
artikel |
69 |
Continuing medical education information
|
|
|
2003 |
22 |
1S |
p. S6-S7 2 p. |
artikel |
70 |
Coronary ectasia in pediatric heart transplant recipients
|
Kaufman, B.D |
|
2003 |
22 |
1S |
p. S133- 1 p. |
artikel |
71 |
Correlation between induced sputum neutrophil percentage and decline from best postoperative baseline in FEV1, FEF25-75 and FEF50
|
Allen, D.J |
|
2003 |
22 |
1S |
p. S192-S193 2 p. |
artikel |
72 |
Cost analysis of universal prophylaxis versus preemptive therapy for cytomegalovirus
|
Crompton, J.A |
|
2003 |
22 |
1S |
p. S187-S188 2 p. |
artikel |
73 |
C2 Targets and multivariate predictors of C2 levels in stable heart transplant patients immunosuppressed on a C0-based regimen
|
Caforio, A.L.P |
|
2003 |
22 |
1S |
p. S117- 1 p. |
artikel |
74 |
Cyclosporin C2 monotoring after lung transplantation (LT) in cystic fibrosis (CF) and non CF patients
|
Bodin, L |
|
2003 |
22 |
1S |
p. S120- 1 p. |
artikel |
75 |
Cyclosporin 2-hr post dose monitoring-a potentially valuable tool for optimising immunosuppresssion after heart transplantation
|
Datta, S |
|
2003 |
22 |
1S |
p. S124- 1 p. |
artikel |
76 |
Cyclsosporin-induced endothelial dysfunction: is tetrahydrobiopterin the solution?
|
El-Hamamsy, I |
|
2003 |
22 |
1S |
p. S98- 1 p. |
artikel |
77 |
Cystic fibrosis and lung transplantation - determination of the survival benefit
|
Aigner, C |
|
2003 |
22 |
1S |
p. S214- 1 p. |
artikel |
78 |
Cytoskeletal protein 4.1 isoforms, newly discovered in heart, are differentially overexpressed in the myocardium of patients with deteriorating heart failure
|
Birks, E.J |
|
2003 |
22 |
1S |
p. S203-S204 2 p. |
artikel |
79 |
25 days of baboons after orthotopic xenotransplantation of hDAF transgenic PIG hearts using a moderate immunosuppression
|
Brandl, U |
|
2003 |
22 |
1S |
p. S100-S101 2 p. |
artikel |
80 |
Declining adverse event and mortality rates over implant duration with the novacor LVAS: implications for destination therapy
|
Rogers, J.G |
|
2003 |
22 |
1S |
p. S196- 1 p. |
artikel |
81 |
De novo alveolar proteinosis in lung transplant recipients
|
Bag, R. |
|
2003 |
22 |
1S |
p. S139- 1 p. |
artikel |
82 |
Depression and neurocognitive deficits are common comorbid conditions in ambulatory heart failure patients
|
Romanelli, J |
|
2003 |
22 |
1S |
p. S126- 1 p. |
artikel |
83 |
Deregulation of cell cycle protein expression by constitutive overexpression of AIF-1 in human coronary artery smooth muscle cells
|
Absaieri, M.V |
|
2003 |
22 |
1S |
p. S98- 1 p. |
artikel |
84 |
Design improvements of the heartmate® VE LVAS and their effectiveness in reducing adverse events
|
Farrar, D.J |
|
2003 |
22 |
1S |
p. S83- 1 p. |
artikel |
85 |
Detection of cardiac allograft rejection by multi-parameter gene expression analysis on circulating mononuclear cells using real-time RT-PCR
|
Schoels, M |
|
2003 |
22 |
1S |
p. S97- 1 p. |
artikel |
86 |
Diagnostic accuracy of coronary angiography and risk factors for post-heart transplant Coronary Artery Vasculopathy (CAV)
|
Sharples, L.D |
|
2003 |
22 |
1S |
p. S208- 1 p. |
artikel |
87 |
Diagnostic value and safety of endomyocardial biopsy in selected patients with heart failure
|
Howe, W.O. |
|
2003 |
22 |
1S |
p. S140- 1 p. |
artikel |
88 |
Differences in patients with left ventricular assist device between dilated cardiomyopathy and dilated phase hypertrophic cardiomyopathy
|
Fukushima, N |
|
2003 |
22 |
1S |
p. S197- 1 p. |
artikel |
89 |
Different cyclosporine regimens and their influences on transplant vasculopathy
|
Richter, M.H.C |
|
2003 |
22 |
1S |
p. S95- 1 p. |
artikel |
90 |
Differential expression of the novel immuno-regulatory growth factors IL-11 and IL-17 in lung transplant recipients
|
Zheng, L |
|
2003 |
22 |
1S |
p. S98-S99 2 p. |
artikel |
91 |
Differential protein expression in plexogenic pulmonary hypertensive lung lesions
|
Southwood, M |
|
2003 |
22 |
1S |
p. S152-S153 2 p. |
artikel |
92 |
Differential regulation of CA2+-dependent atpase-activity in left ventricular myocardium during mechanical circulatory support
|
Milting, H |
|
2003 |
22 |
1S |
p. S198- 1 p. |
artikel |
93 |
Differential trafficking of tolerizing cells in neonatal tolerance induction: fate depends on cell source
|
Lobach, N.E |
|
2003 |
22 |
1S |
p. S104- 1 p. |
artikel |
94 |
Differential vulnerability to psychiatric distress after lung vs. heart transplantation
|
Dew, M.A |
|
2003 |
22 |
1S |
p. S128- 1 p. |
artikel |
95 |
Differentiation of human bone marrow mesenchymal stem cells into airway epithelia
|
Valentine, V.G |
|
2003 |
22 |
1S |
p. S125-S126 2 p. |
artikel |
96 |
Dilutional anemia in patients with advanced heart failure is associated with poor outcome
|
Mancini, D.M |
|
2003 |
22 |
1S |
p. S84-S85 2 p. |
artikel |
97 |
Distribution of collagen subtypes and matrix metalloproteinases in coronary artery vasculopathy
|
Atkinson, C |
|
2003 |
22 |
1S |
p. S97- 1 p. |
artikel |
98 |
Dobutamine stress echocardiography is predictive of events after heart transplantation
|
Pincus, M.W |
|
2003 |
22 |
1S |
p. S174- 1 p. |
artikel |
99 |
Does extended duration of mechanical circulatory support impact clinical outcomes?
|
Mussivand, T |
|
2003 |
22 |
1S |
p. S158-S159 2 p. |
artikel |
100 |
Does functional ability and return to work improve from 1 to 3 years after heart transplantation?
|
White-Williams, C |
|
2003 |
22 |
1S |
p. S219-S220 2 p. |
artikel |
101 |
Does prophylactic ganciclovir therapy after heart transplantation decrease CMV-infection properly?
|
Mueller, M |
|
2003 |
22 |
1S |
p. S157- 1 p. |
artikel |
102 |
Does QRS width really impact on cardiac resynchronization benefit in heart failure patients?
|
Gronda, E |
|
2003 |
22 |
1S |
p. S108-S109 2 p. |
artikel |
103 |
Does statin therapy added to calcium channel blocker reduce development of transplant coronary artery disease in heart transplant survivors?
|
Gao, S.-Z |
|
2003 |
22 |
1S |
p. S177- 1 p. |
artikel |
104 |
Do implantable left ventricular assist devices affect posttransplant survival in the modern era (2000-2002): an analysis of the US scientific registry of transplant recipients
|
Aaronson, K.D |
|
2003 |
22 |
1S |
p. S149-S150 2 p. |
artikel |
105 |
Donor-derived suppressor macrophages for recipient-specific immunosuppression in lung transplantation in minipigs
|
Warnecke, G |
|
2003 |
22 |
1S |
p. S81-S82 2 p. |
artikel |
106 |
Donor designation on the driver’s license: friend or foe?
|
Kfoury, A.G |
|
2003 |
22 |
1S |
p. S88- 1 p. |
artikel |
107 |
Donor intracranial bleeding is associated with advanced transplant coronary vasculopathy: evidence from intravascular ultrasound
|
Yamani, M.H |
|
2003 |
22 |
1S |
p. S76- 1 p. |
artikel |
108 |
Donor intracranial bleeding is associated with upregulation of the angiotensin receptor
|
Yamani, M.H |
|
2003 |
22 |
1S |
p. S212- 1 p. |
artikel |
109 |
Donor intracranial hemorrhage is associated with graft dysfunction and poorer survival following heart transplantation
|
McNeill, A.M |
|
2003 |
22 |
1S |
p. S112-S113 2 p. |
artikel |
110 |
Donor pretreatment using the aerosolized prostacyclin analogue iloprost optimizes postischemic function of non heart beating donor lungs
|
Wittwer, T |
|
2003 |
22 |
1S |
p. S117- 1 p. |
artikel |
111 |
Do older heart transplant recipients have a normal quality of life?
|
Kao, A |
|
2003 |
22 |
1S |
p. S129-S130 2 p. |
artikel |
112 |
Double lung transplantation does not confer a survival advantage over single lung transplanation in COPD
|
Valapour, M |
|
2003 |
22 |
1S |
p. S92- 1 p. |
artikel |
113 |
Double lung transplantation via median sternotomy and with cardiopulmonary bypass is safe and without adverse clinical outcome
|
Dhital, K.K |
|
2003 |
22 |
1S |
p. S185- 1 p. |
artikel |
114 |
Early initiation of aerobic and resistance training improves peak aerobic power, leg-press maximal strength and distance walked in six minutes in recent cardiac transplant recipients
|
Haykowsky, M |
|
2003 |
22 |
1S |
p. S179- 1 p. |
artikel |
115 |
Economic evaluation of everolimus vs. azathioprine as part of triple immunosuppressive therapy in a phase III de novo heart transplant trial
|
Radeva, J.I |
|
2003 |
22 |
1S |
p. S167- 1 p. |
artikel |
116 |
Effectivity of a T-cell adapted induction-therapy with antithymocyte globuline (ATG) sangstad
|
Koch, A |
|
2003 |
22 |
1S |
p. S168- 1 p. |
artikel |
117 |
Effect of brain death on release of brain and atrium natriuretic peptides in an animal model
|
Potapov, E.V |
|
2003 |
22 |
1S |
p. S115- 1 p. |
artikel |
118 |
Effect of folate administration on heart allograft atherosclerosis one year after transplant: a prospective randomized study
|
Potena, L |
|
2003 |
22 |
1S |
p. S75- 1 p. |
artikel |
119 |
Effect of mechanical unloading of left ventricle on right ventricular remodeling
|
Osorio, J.C |
|
2003 |
22 |
1S |
p. S199-S200 2 p. |
artikel |
120 |
Effect of mechanical ventricular unloading on mast cells in failing myocardium
|
Skrabal, C.A |
|
2003 |
22 |
1S |
p. S210- 1 p. |
artikel |
121 |
Effect of rapamycin on anti-HLA donor antibody formation in patients with transplant coronary artery disease
|
Pinney, S.P |
|
2003 |
22 |
1S |
p. S173- 1 p. |
artikel |
122 |
Effect of transplant operation on survival after development of bronchiolitis obliterans syndrome (BOS) in patients with chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF)
|
Hadjiliadis, D |
|
2003 |
22 |
1S |
p. S92-S93 2 p. |
artikel |
123 |
Effects of differing calcineurin based immune therapies on homocysteine levels in cardiac transplant patients
|
Fedoruk, L.M |
|
2003 |
22 |
1S |
p. S150- 1 p. |
artikel |
124 |
Effects of FK506 inhalant on the suppression of acute rejection in lung transplantation: use of rat orthotopic lung transplantation model
|
Ingu, A |
|
2003 |
22 |
1S |
p. S95-S96 2 p. |
artikel |
125 |
Effects of P38 mitogen-activated protein kinase inhibitor as an additive to celsior solution on canine heart transplantation from non-heart-beating donors
|
Koike, N. |
|
2003 |
22 |
1S |
p. S143- 1 p. |
artikel |
126 |
Effects of porcine Gal-negative hematopoietic progenitor cells on primate platelet aggregation and endothelial cell activation - implications for the induction of mixed hematopoetic chimerism in the PIG-to-primate model
|
Knosalla, C |
|
2003 |
22 |
1S |
p. S104-S105 2 p. |
artikel |
127 |
Efficacy and safety of tacrolimus (TAC) vs. cyclosporine microemulsion (CME) in de novo cardiac transplant recipients: 6-month results
|
Grimm, M |
|
2003 |
22 |
1S |
p. S92- 1 p. |
artikel |
128 |
Efficiency of retrograde intracoronary infusion for cell transplantation to the heart
|
Suzuki, K |
|
2003 |
22 |
1S |
p. S126- 1 p. |
artikel |
129 |
Electrophysiological properties of myoblasts injected into the infarcted myocardium of rats
|
Ott, H.C |
|
2003 |
22 |
1S |
p. S79- 1 p. |
artikel |
130 |
Elevated CXCR4 levels on peripheral blood T-cells in heart transplantation patients
|
Athanassopoulos, P |
|
2003 |
22 |
1S |
p. S169-S170 2 p. |
artikel |
131 |
Elevated homocysteine levels accelerate cardiac allograft vasculopathy
|
Kutschka, I |
|
2003 |
22 |
1S |
p. S74-S75 2 p. |
artikel |
132 |
Elevated levels of the CXCR3 chemokine ligand itac is associated with the development of severe transplant coronary artery disease in humans
|
Kao, J |
|
2003 |
22 |
1S |
p. S97-S98 2 p. |
artikel |
133 |
Elevated troponin I in heart failure: a marker for poor prognosis
|
Horwich, T.H |
|
2003 |
22 |
1S |
p. S109- 1 p. |
artikel |
134 |
Emergent mechanical support in the community: improvement with early transplant center referral
|
Morris, R.J |
|
2003 |
22 |
1S |
p. S148-S149 2 p. |
artikel |
135 |
En-bloc vascularized thymus and heart transplantation in miniature swine
|
Johnston, D.R |
|
2003 |
22 |
1S |
p. S88-S89 2 p. |
artikel |
136 |
Enhanced clinical utility of de novo cyclosporin C2 monitoring after lung transplantation
|
Morton, J.M |
|
2003 |
22 |
1S |
p. S119- 1 p. |
artikel |
137 |
Enhanced immune response in CMV D+/R- heart transplant patients receiving combined CMV prophylaxis
|
Bonaros, N.E |
|
2003 |
22 |
1S |
p. S171- 1 p. |
artikel |
138 |
Equivalent survival despite higher risk profile in african american heart transplant recipients
|
Gupta, D |
|
2003 |
22 |
1S |
p. S172- 1 p. |
artikel |
139 |
Evaluation of an oral CXCR3 antagonist in a rat model of acute cardiac allograft rejection
|
Bowdish, M.E |
|
2003 |
22 |
1S |
p. S162- 1 p. |
artikel |
140 |
Evaluation of changes in functional capacity, quality of life and hospital days following participation in cardiopulmonary rehab in patients with congestive heart failure
|
Houston-Feenstra, L |
|
2003 |
22 |
1S |
p. S107- 1 p. |
artikel |
141 |
Everolimus dose recommendations in de novo heart transplantation - TDM simulations
|
Starling, R.C. |
|
2003 |
22 |
1S |
p. S140- 1 p. |
artikel |
142 |
Everolimus in de novo cardiac transplant recipients: 24-month follow-up
|
Haverich, A. |
|
2003 |
22 |
1S |
p. S140-S141 2 p. |
artikel |
143 |
Everolimus is associated with a reduced incidence of CMV infection in heart transplantation
|
Dorent, R. |
|
2003 |
22 |
1S |
p. S141-S142 2 p. |
artikel |
144 |
Exercise assessment in children after cardiac transplant in infancy: effect of chronotropic incompetence
|
Abarbanell, G.L. |
|
2003 |
22 |
1S |
p. S144- 1 p. |
artikel |
145 |
Exogenous surfactant instillation in lung donors to reduce early graft dysfunction
|
Strueber, M. |
|
2003 |
22 |
1S |
p. S142- 1 p. |
artikel |
146 |
Experience of severe fulminant myocarditis with shock by extracorporeal membrane oxygenation - what mechanical support should be considered first?
|
Chen, Y.S |
|
2003 |
22 |
1S |
p. S211-S212 2 p. |
artikel |
147 |
Expression of allograft inflammatory factor-1 in T-lymphocytes: a role in T-cell activation and allograft rejection
|
Kelemen, S.E |
|
2003 |
22 |
1S |
p. S102- 1 p. |
artikel |
148 |
Expression of connective tissue growth factor is upregulated in post-transplant obliterative airway disease
|
Thanikachalam, M |
|
2003 |
22 |
1S |
p. S101- 1 p. |
artikel |
149 |
Extracorporeal membrane oxygenation (ECMO) as a bridge to heart transplantation in children
|
Perez, R |
|
2003 |
22 |
1S |
p. S215- 1 p. |
artikel |
150 |
Factors influencing mycophenolate mofetil drug exposure in thoracic organ transplant recipients
|
Partovi, N |
|
2003 |
22 |
1S |
p. S121- 1 p. |
artikel |
151 |
Fk 778, a novel immunosuppressive agent reduces early adhesion molecule upregulation after cardiac transplantation
|
Deuse, T |
|
2003 |
22 |
1S |
p. S94-S95 2 p. |
artikel |
152 |
Full viability of the myocardium after twenty-four hour organ conservation
|
Martin, J |
|
2003 |
22 |
1S |
p. S114- 1 p. |
artikel |
153 |
Functional outcomes of lobar and double lung transplant recipients
|
Rodrigues, J.S |
|
2003 |
22 |
1S |
p. S93- 1 p. |
artikel |
154 |
Functional recovery of heart failure patients in cardiogenic shock treated with paracorporeal biventricular support
|
Vogel, C.N |
|
2003 |
22 |
1S |
p. S126-S127 2 p. |
artikel |
155 |
Gamma-interferon-dependent T cell-mediated injury and remodeling of human coronary arteries
|
Wang, Y |
|
2003 |
22 |
1S |
p. S154-S155 2 p. |
artikel |
156 |
Gene expression in cardiac and lung xenografts
|
Waddell, T.K |
|
2003 |
22 |
1S |
p. S90- 1 p. |
artikel |
157 |
General meeting information
|
|
|
2003 |
22 |
1S |
p. S8-S9 2 p. |
artikel |
158 |
Geometric disproportion of cardiac structures affects atrioventricular valve insufficiency in neonatal cardiac transplant
|
Asano, M |
|
2003 |
22 |
1S |
p. S135- 1 p. |
artikel |
159 |
Granzyme B, a cytotoxic immune protease, induces apoptosis of smooth muscle cells in the absence of perforin
|
Choy, J.C |
|
2003 |
22 |
1S |
p. S155- 1 p. |
artikel |
160 |
Growth hormone therapy following pediatric cardiac transplantation
|
Mital, S |
|
2003 |
22 |
1S |
p. S215- 1 p. |
artikel |
161 |
Health related quality of life of elderly patients with end-stage heart failure
|
Doering, L.V |
|
2003 |
22 |
1S |
p. S128- 1 p. |
artikel |
162 |
Health-related quality of life outcomes in patients with pulmonary hypertension
|
Shafazand, S |
|
2003 |
22 |
1S |
p. S185-S186 2 p. |
artikel |
163 |
Heart failure demands more biventricular mechanical circulatory support
|
Sapirstein, J.S |
|
2003 |
22 |
1S |
p. S148- 1 p. |
artikel |
164 |
Heart failure survival score continues to predict death or unos 1 transplant in heart failure patients receiving beta blockers
|
Koelling, T.M |
|
2003 |
22 |
1S |
p. S216- 1 p. |
artikel |
165 |
Hearts transfected with inducible nitric oxide synthase have accelerated restoration of cardiac function following ischemia/reperfusion associated with cardiac transplantation
|
Shears, L.L. |
|
2003 |
22 |
1S |
p. S143-S144 2 p. |
artikel |
166 |
Heart transplantation in diabetic recipients: a decade review of 161 patients at columbia presbyterian
|
Morgan, J.A |
|
2003 |
22 |
1S |
p. S209-S210 2 p. |
artikel |
167 |
Heart transplant in recipients older than 60 years. insights after more than 10 years of follow-up
|
Segovia, J |
|
2003 |
22 |
1S |
p. S168-S169 2 p. |
artikel |
168 |
Hemodynamic impact of biventricular pacing in candidates for heart transplantation
|
Naegele, H |
|
2003 |
22 |
1S |
p. S109- 1 p. |
artikel |
169 |
Highlights of the scientific program
|
|
|
2003 |
22 |
1S |
p. S10-S12 3 p. |
artikel |
170 |
High potassium lung preservation solutions increase production of NADPH oxidase-dependent reactive oxygen species
|
Murar, J |
|
2003 |
22 |
1S |
p. S101-S102 2 p. |
artikel |
171 |
Hormonal therapy stabilizes hemodynamics during donor procurement
|
Van Bakel, A.B. |
|
2003 |
22 |
1S |
p. S142- 1 p. |
artikel |
172 |
Hotel rates and cancellation policy
|
|
|
2003 |
22 |
1S |
p. S18- 1 p. |
artikel |
173 |
Housing registration form
|
|
|
2003 |
22 |
1S |
p. S17- 1 p. |
artikel |
174 |
How to improve organ donation: the results of the ISHLT/FACT poll
|
Kherani, A.R |
|
2003 |
22 |
1S |
p. S127- 1 p. |
artikel |
175 |
How to predict forced vital capacity of the recipient after living-donor lobar lung transplantation
|
Date, H |
|
2003 |
22 |
1S |
p. S181- 1 p. |
artikel |
176 |
Human umbilical cord cells for tissue engineering of trileaflet heart valves
|
Kadner, A |
|
2003 |
22 |
1S |
p. S125- 1 p. |
artikel |
177 |
Hypogammaglobulinemia in pediatric lung transplant recipients is associated with increase mortality
|
De la Morena, M.T |
|
2003 |
22 |
1S |
p. S132-S133 2 p. |
artikel |
178 |
Identification of MIP-1β and VE-Cadherin as important markers of acute rejection following human heart transplantation
|
Roussoulieres, A.L.S |
|
2003 |
22 |
1S |
p. S178- 1 p. |
artikel |
179 |
Identifying optimal heart failure patients for forced titration of vasodilator threapy despite “low” initial systolic blood pressures: a cardiac bioimpedance study
|
Saltzberg, M.T |
|
2003 |
22 |
1S |
p. S167- 1 p. |
artikel |
180 |
Idiopathic dilated cardiomyopathy a major predisposing factor for early rejection: relevance to outcome
|
Warraich, R.S |
|
2003 |
22 |
1S |
p. S167- 1 p. |
artikel |
181 |
IL-6 and TNFα cytokine genotypes are associated with acute rejection and lower survival in African American heart transplant recipients
|
Coleman, B.L |
|
2003 |
22 |
1S |
p. S216-S217 2 p. |
artikel |
182 |
IL-10 high genotype is protective against acute persistent rejection after lung transplantation
|
Zheng, H.X |
|
2003 |
22 |
1S |
p. S77-S78 2 p. |
artikel |
183 |
IL-1β in broncho-alveolar lavage is a non-invasive predictor of the viability of the pulmonary graft from the non-heart-beating donor
|
Rega, F |
|
2003 |
22 |
1S |
p. S213- 1 p. |
artikel |
184 |
IL-10 induces suppressor of cytokine secretion-3 (SOCS-3) and ILT-3 in human endothelial cells and inhibits T cell costimulation
|
Gleissner, C |
|
2003 |
22 |
1S |
p. S81- 1 p. |
artikel |
185 |
Immunology properties of rat vascular endothelium
|
Riha, M |
|
2003 |
22 |
1S |
p. S107- 1 p. |
artikel |
186 |
Immunosuppressive effects of FK506 inhalant on acute rejection in lung transplantation
|
Ingu, A |
|
2003 |
22 |
1S |
p. S121- 1 p. |
artikel |
187 |
Impact of anticoagulant and antiplatelet regimens on graft survival in PIG-to-primate cardiac xenotransplantation
|
Schirmer, J.M |
|
2003 |
22 |
1S |
p. S102-S103 2 p. |
artikel |
188 |
Impact of BMI on long-term survival after heart transplantation
|
Eisen, H.J |
|
2003 |
22 |
1S |
p. S170- 1 p. |
artikel |
189 |
Impact of bronchogenic carcinoma in patients undergoing lung transplantation. results of an international survey
|
de Perrot, M |
|
2003 |
22 |
1S |
p. S161- 1 p. |
artikel |
190 |
Impact of donor characteristics in pediatric heart transplant recipients
|
Lamour, J.M |
|
2003 |
22 |
1S |
p. S133- 1 p. |
artikel |
191 |
Impact of donor serum sodium levels on outcome after heart transplantation
|
Kaczmarek, I |
|
2003 |
22 |
1S |
p. S111- 1 p. |
artikel |
192 |
Impact of donor smoking on survival after lung transplantation
|
Waddell, T.K |
|
2003 |
22 |
1S |
p. S114-S115 2 p. |
artikel |
193 |
Impact of donor-transmitted coronary atherosclerosis
|
Grauhan, O |
|
2003 |
22 |
1S |
p. S213-S214 2 p. |
artikel |
194 |
Impact of health insurance and black race on outcome after cardiac transplantation: analysis of the cardiac transplant research database
|
Montpetit, M.C |
|
2003 |
22 |
1S |
p. S208-S209 2 p. |
artikel |
195 |
Impact of new therapies on the prevalence of coronary artery disease in heart transplant survivors: stanford experience
|
Gao, S.-Z |
|
2003 |
22 |
1S |
p. S173- 1 p. |
artikel |
196 |
Impact of post-transplant antibody in a re-examination of humoral rejection diagnosis
|
Takemoto, S.K |
|
2003 |
22 |
1S |
p. S170-S171 2 p. |
artikel |
197 |
Implantable cardioverter defibrillators in heart transplant patients at risk for sudden death: shocking news?
|
Cogert, G.A |
|
2003 |
22 |
1S |
p. S178-S179 2 p. |
artikel |
198 |
Implantation of a cardiac support device as adjunct to CABG in ischemic cardiomyopathy
|
Castel, M.A |
|
2003 |
22 |
1S |
p. S158- 1 p. |
artikel |
199 |
Improved overall outcome with the micromed debakey LVAD as bridge to transplant
|
Salzberg, S |
|
2003 |
22 |
1S |
p. S206- 1 p. |
artikel |
200 |
Improved right ventricular structure following LVAD support in patients with end-stage cardiomyopathy
|
Kucuker, S.A |
|
2003 |
22 |
1S |
p. S211- 1 p. |
artikel |
201 |
Improved survival after diagnosis of cardiac allograft vasculopathy (CAV) through extreme reduction of cholesterol and fibrinogen
|
Jaeger, B.R. |
|
2003 |
22 |
1S |
p. S75- 1 p. |
artikel |
202 |
Improved survival with statin therapy in ischemic and non-ischemic heart failure
|
Horwich, T.B |
|
2003 |
22 |
1S |
p. S159- 1 p. |
artikel |
203 |
Incidence and outcome of malignancies in patients after heart transplantation
|
Ruzicka, M |
|
2003 |
22 |
1S |
p. S168- 1 p. |
artikel |
204 |
Incidence of non-cellular (humoral) rejection unchanged in the 1990 decade despite a decrease in cellular rejection
|
Cogert, G.A |
|
2003 |
22 |
1S |
p. S119-S120 2 p. |
artikel |
205 |
Incidence of right ventricular failure and the role of concomitant coronary revascularization during LVAD implantation
|
Park, S.J |
|
2003 |
22 |
1S |
p. S200- 1 p. |
artikel |
206 |
Increased expression of CD40, B7–2, interleukin-15 and granzyme B in bronchoalveolar lavage cells from human lung transplant recipients
|
Mohanakumar, T |
|
2003 |
22 |
1S |
p. S186- 1 p. |
artikel |
207 |
Increased expression of single-strand DNA-binding proteins represses alpha-myosin heavy chain (MHC) gene expression in heart failure
|
Raman, J |
|
2003 |
22 |
1S |
p. S106- 1 p. |
artikel |
208 |
Increased incidence of severe lung allograft acute rejection in patients exhibiting HLA-specific antibodies
|
Zeevi, A |
|
2003 |
22 |
1S |
p. S162-S163 2 p. |
artikel |
209 |
Increased thoracic organ ultilization using an advanced practice organ procurement coordinator
|
Babcock, W.D |
|
2003 |
22 |
1S |
p. S88- 1 p. |
artikel |
210 |
Index to authors of abstracts
|
|
|
2003 |
22 |
1S |
p. S222-S234 13 p. |
artikel |
211 |
Indirect allorecognition of MHC class II peptides accellerates cardiac allograft rejection in miniature swine
|
Johnston, D.R |
|
2003 |
22 |
1S |
p. S82- 1 p. |
artikel |
212 |
Induction of tolerance to a minor histocompatibility antigen prevents post-transplant obliterative airway disease in mouse tracheal allografts
|
Mohanakumar, T |
|
2003 |
22 |
1S |
p. S82- 1 p. |
artikel |
213 |
Induction therapy with two doses of daclizumab in heart transplantation: a prospective, multi centric clinical study. interim analysis
|
Rabago, G |
|
2003 |
22 |
1S |
p. S123- 1 p. |
artikel |
214 |
Infection in permanent circulatory support: experience from the randomized evaluation of mechanical assistance in the treatment of congestive heart failure (rematch) trial
|
Holman, W |
|
2003 |
22 |
1S |
p. S82-S83 2 p. |
artikel |
215 |
Infectious complications in heart transplantation are influenced by ethnic disparities in immunoglobulin expression
|
Mehra, M.R |
|
2003 |
22 |
1S |
p. S175- 1 p. |
artikel |
216 |
Inflammatory markers in BAL and breath condensate early and late after lung transplantation
|
Hofer, M |
|
2003 |
22 |
1S |
p. S188-S189 2 p. |
artikel |
217 |
Influence of an anti-CD25 mAB on tolerance induction through BMT with costimulation blockade
|
Bigenzahn, S |
|
2003 |
22 |
1S |
p. S81- 1 p. |
artikel |
218 |
Inhaled iloprost as a bridge to transplant in advanced pulmonary fibrosis and secondary pulmonary hypertension
|
Moloney, E.D |
|
2003 |
22 |
1S |
p. S194- 1 p. |
artikel |
219 |
Inhaled milrinone and prostacyclin for ventricular assist device recipients: effectiveness and cost
|
Etoch, S.W |
|
2003 |
22 |
1S |
p. S149- 1 p. |
artikel |
220 |
Inhibition of human NK cell mediated cytotxicity to pig endothelial cells by over expression of human ecto-5′-nucleotidase
|
Osborne, F.N |
|
2003 |
22 |
1S |
p. S90- 1 p. |
artikel |
221 |
Inhibition of poly-ADP ribose synthase (PARS) increases cardiac myocyte survival during acute cardiac allograft rejection in rats
|
Szabolcs, M.J |
|
2003 |
22 |
1S |
p. S105- 1 p. |
artikel |
222 |
Inhibition of poly (ADP) ribose synthetase ameliorates experimental obliterative bronchiolitis in rat tracheal allografts
|
Farivar, A.S |
|
2003 |
22 |
1S |
p. S155- 1 p. |
artikel |
223 |
Initial clinical experience with the thoratec IVAD: a versatile implantable UNI- or BI-ventricular assist device
|
Tsui, S |
|
2003 |
22 |
1S |
p. S201- 1 p. |
artikel |
224 |
Initial European experience with the lionheart(TM) LVAS (Left Ventricular Assist System)for destination therapy
|
Pae, W.E |
|
2003 |
22 |
1S |
p. S83- 1 p. |
artikel |
225 |
iNOS and peroxynitrite formation during acute rejection after human heart transplantation
|
Birks, E.J |
|
2003 |
22 |
1S |
p. S137- 1 p. |
artikel |
226 |
Interleukin-4 and -10 combined gene therapy induces cardiac allograft tolerance by promoting the alloreactive T cells apoptosis and preventing myocytes apoptosis via Fas/FasL pathway
|
Furukawa, H |
|
2003 |
22 |
1S |
p. S80-S81 2 p. |
artikel |
227 |
Interleukin-6 and risk of coronary artery disease and graft failure in heart transplant recipients
|
Labarrere, C.A |
|
2003 |
22 |
1S |
p. S164- 1 p. |
artikel |
228 |
Interleukin-6 is the most potent predictor for worsening of heart failure in patients with congestive heart failure
|
Gwechenberger, M |
|
2003 |
22 |
1S |
p. S85-S86 2 p. |
artikel |
229 |
International society for heart and lung transplantation
|
|
|
2003 |
22 |
1S |
p. S1- 1 p. |
artikel |
230 |
Inter-observer variability in grading acute rejection in endomyocardial biopsies
|
Lindop, G.B.M |
|
2003 |
22 |
1S |
p. S96- 1 p. |
artikel |
231 |
Inter-reader and intra-reader agreement for grading acute rejection and airway inflammation after lung transplantation, based on the lung rejection study group revised working formulation
|
Chakinala, M.M |
|
2003 |
22 |
1S |
p. S96- 1 p. |
artikel |
232 |
Intracoronary interferon-γ promotes vasculopathy in tolerant miniature swine bearing mhc class I disparate hearts
|
Hoerbelt, R |
|
2003 |
22 |
1S |
p. S102- 1 p. |
artikel |
233 |
Intravenous ribavirin : effective therapy for respiratory syncytial virus (RSV) infection after lung transplantation
|
Scott, A.R |
|
2003 |
22 |
1S |
p. S192- 1 p. |
artikel |
234 |
Is acute rejection primary in the development of obliterative bronchiolitis? a retrospective study of daclizumab and thymoglobulin
|
Conte, J.V |
|
2003 |
22 |
1S |
p. S122- 1 p. |
artikel |
235 |
Ischemic reperfusion injury to donor lung endothelium is mediated through gene promoter NF-KB and upstream IKK kinase
|
Bhullar, I.S |
|
2003 |
22 |
1S |
p. S115- 1 p. |
artikel |
236 |
ISHLT Registration form
|
|
|
2003 |
22 |
1S |
p. S15- 1 p. |
artikel |
237 |
ISHLT registration policies
|
|
|
2003 |
22 |
1S |
p. S16- 1 p. |
artikel |
238 |
ISHLT tour descriptions/dates/prices
|
|
|
2003 |
22 |
1S |
p. S20-S22 3 p. |
artikel |
239 |
ISHLT tour registration form
|
|
|
2003 |
22 |
1S |
p. S19- 1 p. |
artikel |
240 |
Is interstitial lung disease a risk factor for mortality in pediatric lung transplantion?
|
Guleserian, K.J |
|
2003 |
22 |
1S |
p. S215-S216 2 p. |
artikel |
241 |
Is invasive fungal disease in lung transplant recipients predictable?
|
Plit, M.L |
|
2003 |
22 |
1S |
p. S193- 1 p. |
artikel |
242 |
Is low frequency of donor specific interleukin 10 (IL10) producing cells in peripheral blood (PB) of heart transplant recipients related to graft rejection?
|
Paschetto, E |
|
2003 |
22 |
1S |
p. S164-S165 2 p. |
artikel |
243 |
Is recrudescent tobacco exposure following heart transplantation associated with expression of atherothrombosis risk markers?
|
Mehra, M.R |
|
2003 |
22 |
1S |
p. S178- 1 p. |
artikel |
244 |
Is the alternate waiting list too high risk? The columbia-presbyterian experience
|
Chen, J.M |
|
2003 |
22 |
1S |
p. S175- 1 p. |
artikel |
245 |
Is there a need for a tailored immunosuppression in elderly heart transplant recipients?
|
Kaczmarek, I |
|
2003 |
22 |
1S |
p. S217- 1 p. |
artikel |
246 |
ITO and IR potassium channel (K+) expression and regulation during severe left ventricular dysfunction (LVD) and ventricular unloading
|
Maybaum, S |
|
2003 |
22 |
1S |
p. S200- 1 p. |
artikel |
247 |
L-Arginine improves endothelial and myocardial function after brain death
|
Szabo, G |
|
2003 |
22 |
1S |
p. S113-S114 2 p. |
artikel |
248 |
Late cardiac allograft rejection ISHLT grade ≥3A resolves spontaneously and is not subject to an era effect
|
Klingenberg, R |
|
2003 |
22 |
1S |
p. S136-S137 2 p. |
artikel |
249 |
Left ventricular assist device replacement
|
Long, J.W |
|
2003 |
22 |
1S |
p. S83-S84 2 p. |
artikel |
250 |
Left ventricular mechanical unloading decreases ischemic susceptibility by modulating angiotensin II type-2 receptor gene experssion in the failing heart after myocardial infarction
|
Horimoto, S |
|
2003 |
22 |
1S |
p. S197- 1 p. |
artikel |
251 |
Left ventricular shape change with myosplint® implantation in dilative cardiomyopathy: clinical experience in 9 patients
|
Rahmel, A |
|
2003 |
22 |
1S |
p. S158- 1 p. |
artikel |
252 |
Liberalization of donor criteria does not compromise outcomes three years after lung transplantation
|
Bhorade, S.M |
|
2003 |
22 |
1S |
p. S212-S213 2 p. |
artikel |
253 |
Liver failure following mechanical circulatory support: improving outcome with application of MARS technique
|
El-Banayosy, A |
|
2003 |
22 |
1S |
p. S219- 1 p. |
artikel |
254 |
Lobectomy to downsize donor lungs for use in small recipients
|
Lau, C.L |
|
2003 |
22 |
1S |
p. S116-S117 2 p. |
artikel |
255 |
Localization of TGF-β1 and type II receptor in end stage emphysema of lung transplanted patients
|
Calabrese, F |
|
2003 |
22 |
1S |
p. S138- 1 p. |
artikel |
256 |
Long term follow-up of a prospective randomized trial comparing tacrolimus versus cyclosporine in combination with MMF after lung transplantation
|
Zuckermann, A |
|
2003 |
22 |
1S |
p. S76-S77 2 p. |
artikel |
257 |
Long-term functional outcome after living-donor lung transplantation in adults
|
Bowdish, M.E |
|
2003 |
22 |
1S |
p. S94- 1 p. |
artikel |
258 |
Long-term neuropsychological sequelae of infant cardiac transplant recipients: trends and predictors of outcome
|
Babikian, T. |
|
2003 |
22 |
1S |
p. S144-S145 2 p. |
artikel |
259 |
Long-term outcome of coronary artery surgery for ischemic cardiomyopathy - a multi-institutional experience
|
Raman, J |
|
2003 |
22 |
1S |
p. S109-S110 2 p. |
artikel |
260 |
Long term results of the domino procedure from cystic fibrosis live donors
|
Aravot, D |
|
2003 |
22 |
1S |
p. S183- 1 p. |
artikel |
261 |
Long term survival following left ventricular assist and comprehensive medical management as bridge to recovery therapy for advanced heart failure
|
Silver, M.A |
|
2003 |
22 |
1S |
p. S211- 1 p. |
artikel |
262 |
Lung transplantation in infancy
|
Mendeloff, E.N. |
|
2003 |
22 |
1S |
p. S144- 1 p. |
artikel |
263 |
Lung transplantation in patients with pulmonary sarcoidosis
|
Milman, N |
|
2003 |
22 |
1S |
p. S189- 1 p. |
artikel |
264 |
Lung transplantation in recipients with previous lung volume reduction surgery
|
Lau, C.L |
|
2003 |
22 |
1S |
p. S183- 1 p. |
artikel |
265 |
Lung transplantation with donors 60 years of age and older
|
de Perrot, M |
|
2003 |
22 |
1S |
p. S87- 1 p. |
artikel |
266 |
Lung Transplant Recipients (LTR) have persistant abnormalities in Bronchoalveolar Lavage(BAL) and endobronchial biopsy(EBB): interim results from a study of RAD vs azathioprine(AZA)
|
Levvey, B.J |
|
2003 |
22 |
1S |
p. S191- 1 p. |
artikel |
267 |
LVAD driveline infections in the modern era : incidence risk factors and strategies for reduction
|
Stanford, E.A |
|
2003 |
22 |
1S |
p. S131- 1 p. |
artikel |
268 |
Lymphoproliferative disease following lung transplant: postitive results with rituximab as primary therapy
|
Lien, D.C |
|
2003 |
22 |
1S |
p. S160-S161 2 p. |
artikel |
269 |
Magnetic resonance measurements of cornary flow reserve: relationship to coronary angiographic findings
|
Kennedy, K |
|
2003 |
22 |
1S |
p. S91- 1 p. |
artikel |
270 |
Managing patients with left ventricular assist device at home, results with 37 patient-years of experience
|
Khodaverdian, R |
|
2003 |
22 |
1S |
p. S206- 1 p. |
artikel |
271 |
Marginal donors in shortage era: impact on recipient’s long-term outcomes
|
Gambino, A |
|
2003 |
22 |
1S |
p. S116- 1 p. |
artikel |
272 |
Maternal and foetal outcome following pregnancy after intrathoracic organ transplantation: single centre experience in 21 patients
|
Nair, K.S |
|
2003 |
22 |
1S |
p. S160- 1 p. |
artikel |
273 |
May preservation solution affect the incidence of graft vasculopathy in transplanted heart?
|
Garlicki, M |
|
2003 |
22 |
1S |
p. S76- 1 p. |
artikel |
274 |
Measuring physical activity among female heart transplant recipients
|
Evangelista, L.S |
|
2003 |
22 |
1S |
p. S220- 1 p. |
artikel |
275 |
Mechanical circulatory assistance with pulsatile or continuous flow devices leads to molecular remodeling of dystrophin: evidence for improvement in the failing left and right ventricle
|
Vatta, M |
|
2003 |
22 |
1S |
p. S219- 1 p. |
artikel |
276 |
Mechanical circulatory support of 22 patients with the original uncoated debakey VAD®
|
Wilhelm, M.J |
|
2003 |
22 |
1S |
p. S199- 1 p. |
artikel |
277 |
Mechanical support for isolated RV failure in post-cardiotomy patients
|
Moazami, N |
|
2003 |
22 |
1S |
p. S206-S207 2 p. |
artikel |
278 |
Medication noncompliance > 1 year after heart transplantation predicts posttransplant outcome: a 5 years follow-up survival analysis study
|
Dobbels, F |
|
2003 |
22 |
1S |
p. S147-S148 2 p. |
artikel |
279 |
Medium term results of ECMO for severe acute lung injury following lung transplantation
|
Dahlberg, P.S |
|
2003 |
22 |
1S |
p. S159-S160 2 p. |
artikel |
280 |
Microalbuminuria in heart transplant patients: association with the development of allograft vasculopathy
|
Rockx, M.A |
|
2003 |
22 |
1S |
p. S176- 1 p. |
artikel |
281 |
MIG/CXCL9 neutralization attenuates chronic rejection of transplanted hearts
|
Whiting, D |
|
2003 |
22 |
1S |
p. S154- 1 p. |
artikel |
282 |
Migration of mesenchymal progenitors to heart allograft: evidence for active participation of mesenchymal stem cells in tissue repair and inadvertent attribution to graft fibrosis
|
Wu, G.D |
|
2003 |
22 |
1S |
p. S125- 1 p. |
artikel |
283 |
Monocyte-induced endothelial calcium signaling mediates E-selectin and VCAM-1 expression on xenogeneic endothelium
|
Peterson, M.D |
|
2003 |
22 |
1S |
p. S105- 1 p. |
artikel |
284 |
Multi-organ transplantation: is there a protective effect against acute and chronic rejection?
|
Pinderski, L |
|
2003 |
22 |
1S |
p. S182- 1 p. |
artikel |
285 |
Multiple combination bactericidal testing (MCBT) for patients with multiresistant Pseudomonas aeruginosa undergoing lung transplantation
|
Scott, A.R |
|
2003 |
22 |
1S |
p. S181- 1 p. |
artikel |
286 |
Mycophenolate mofetil: clinical applications and pharmacokinetic monitoring in pediatric heart transplant recipients
|
Dipchand, A.I |
|
2003 |
22 |
1S |
p. S134- 1 p. |
artikel |
287 |
Mycophenolate mofetil dose and serum level correlation in young cardiac transplant patients
|
Gajarski, R.J |
|
2003 |
22 |
1S |
p. S133-S134 2 p. |
artikel |
288 |
Mycophenolate Mofetil (MMF) vs Azathioprine (AZA) in lung transplantation for the prevention of Bronchiolitis Obliterans Syndrome (BOS): results of a 3 year international randomised trial
|
Glanville, A.R |
|
2003 |
22 |
1S |
p. S207- 1 p. |
artikel |
289 |
Mycophenolic mofetil reduces the alloimmune response of children to surgical valved allograft implantation
|
Shaddy, R.E |
|
2003 |
22 |
1S |
p. S214-S215 2 p. |
artikel |
290 |
Myocardial structural recovery is associated with apoptosis inactivation in biomechanical unloaded heart by LVAD therapy
|
Vatta, M |
|
2003 |
22 |
1S |
p. S210- 1 p. |
artikel |
291 |
Myocardial velocity patterns of tissue doppler imaging in pre-terminal heart transplantation in pediatric patients
|
Fyfe, D.A |
|
2003 |
22 |
1S |
p. S172- 1 p. |
artikel |
292 |
Natriuretic peptides as predictors of clinical course in patients with end-stage heart failure
|
Potapov, E.V |
|
2003 |
22 |
1S |
p. S206- 1 p. |
artikel |
293 |
Natural killer cell-derived cytokines are central in monocyte infiltration and rejection of porcine xenografts
|
Itescu, S |
|
2003 |
22 |
1S |
p. S89- 1 p. |
artikel |
294 |
Natural killer cells can mediate cardiac allograft vasculopathy in murine allografts
|
Rose, H.S |
|
2003 |
22 |
1S |
p. S154- 1 p. |
artikel |
295 |
Nebulised iloprost in pulmonary arterial hypertension due to eisenmengers syndrome
|
Reichenberger, F |
|
2003 |
22 |
1S |
p. S153- 1 p. |
artikel |
296 |
Negative effect of CMV donor status on graft survival after lung but not heart transplantation is restricted to HLA-A2 negative recipients
|
Bonatti, H |
|
2003 |
22 |
1S |
p. S161- 1 p. |
artikel |
297 |
Nesiritide use in end stage heart failure
|
Truong, K.M |
|
2003 |
22 |
1S |
p. S110- 1 p. |
artikel |
298 |
Neurohormonal activation in congestive heart failure: does it normalize after heart transplantation?
|
Ferrer, E |
|
2003 |
22 |
1S |
p. S217-S218 2 p. |
artikel |
299 |
Neutrophil defensin concentrations in pediatric lung transplant recipients
|
Faro, A |
|
2003 |
22 |
1S |
p. S132- 1 p. |
artikel |
300 |
New combination of immunosuppressive therapy decreases acute rejection in lung transplantation
|
Bhorade, S.M |
|
2003 |
22 |
1S |
p. S120- 1 p. |
artikel |
301 |
Non-invasive molecular screening for acute cardiac rejection: a multicenter prospective clinical study
|
Eisen, H.J |
|
2003 |
22 |
1S |
p. S74- 1 p. |
artikel |
302 |
Non-invasive monitoring of acute rejection in heart transplantation: a reappraisal of summated QRS voltage amplitude on ECG
|
Caforio, A.L.P |
|
2003 |
22 |
1S |
p. S173- 1 p. |
artikel |
303 |
Non-invasive screening by tissue doppler for late post-transplant cardiac rejection surveillance
|
Dandel, M |
|
2003 |
22 |
1S |
p. S90-S91 2 p. |
artikel |
304 |
Normalization of left ventricular size and systolic function after diagnosis of pediatric dilated cardiomyopathy
|
Tsirka, A.E |
|
2003 |
22 |
1S |
p. S136- 1 p. |
artikel |
305 |
Novacor left ventricular assist bridge to transplant: no sensitization or excess rejection as compared to unsupported patients
|
Baran, D.A |
|
2003 |
22 |
1S |
p. S195- 1 p. |
artikel |
306 |
Novel application of thoratec VAD as a paracorporeal total artificial heart
|
El-Banayosy, A |
|
2003 |
22 |
1S |
p. S198-S199 2 p. |
artikel |
307 |
N-terminal brain natriuretic peptide: the new gold standard in predicting mortality in patients with advanced heart failure
|
Gardner, R.S |
|
2003 |
22 |
1S |
p. S85- 1 p. |
artikel |
308 |
Obesity and advanced heart failure: the differential impact of body weight on b-type natriuretic peptide and proinflammatory cytokine expression
|
Mehra, M.R |
|
2003 |
22 |
1S |
p. S85- 1 p. |
artikel |
309 |
One-year results of an international, randomized, double-blind study of everolimus vs azathioprine as adjunctive therapy to inhibit the decline of pulmonary function in stable lung or heart/lung transplant recipients
|
Snell, G.I |
|
2003 |
22 |
1S |
p. S207-S208 2 p. |
artikel |
310 |
Optimal immunosuppression post cardiac transplantation: clinical outcomes of long-term cyclosporine monotherapy in a large patient population
|
Rockx, M.A |
|
2003 |
22 |
1S |
p. S119- 1 p. |
artikel |
311 |
Optimization of a novel low-stength electroporation system for ex vivio gene transfer in human heart
|
Sen, L |
|
2003 |
22 |
1S |
p. S106-S107 2 p. |
artikel |
312 |
Outcome after cardiac transplantation - influence of allocation modus
|
Costard-Jäckle, A |
|
2003 |
22 |
1S |
p. S209- 1 p. |
artikel |
313 |
Outcome of heart transplantation using refurbished allografts
|
Odim, J |
|
2003 |
22 |
1S |
p. S87- 1 p. |
artikel |
314 |
Outcomes from 100 patients treated with implantable LVAD therapy: are we ready for destination therapy?
|
Smolens, I.A |
|
2003 |
22 |
1S |
p. S201-S202 2 p. |
artikel |
315 |
Oxygenation improvement and pulmonary vasodilation with Nitric Oxide (NO) or alprostadil immediately after lung transplantation
|
Bulpa, P |
|
2003 |
22 |
1S |
p. S186- 1 p. |
artikel |
316 |
Oxygen consumption predicts outcomes in lung transplant candidates with pulmonary fibrosis
|
Kawut, S.M |
|
2003 |
22 |
1S |
p. S182- 1 p. |
artikel |
317 |
Paraoxonase-1 M55l single nucleotide polymorphism: a new mutation associated with transplant coronary artery disease?
|
Miriuka, S.G |
|
2003 |
22 |
1S |
p. S75-S76 2 p. |
artikel |
318 |
Patient adherence at 5 to 6 years after heart transplantation
|
Bellg, A.J |
|
2003 |
22 |
1S |
p. S127- 1 p. |
artikel |
319 |
Patient factors influencing waiting time to heart transplant in the UK and Republic of Ireland
|
Hudson, A.J |
|
2003 |
22 |
1S |
p. S217- 1 p. |
artikel |
320 |
Perception is deceiving; the real gender specific exercise capacity of heart transplant recipients
|
Cole, B.T |
|
2003 |
22 |
1S |
p. S220-S221 2 p. |
artikel |
321 |
Perioperative complications after living-donor lobar lung transplantation
|
Sano, Y |
|
2003 |
22 |
1S |
p. S188- 1 p. |
artikel |
322 |
Perioperative use of neseritide in heart failure patients undergoing implantation of left ventricular assist device
|
Radovancevic, B |
|
2003 |
22 |
1S |
p. S201- 1 p. |
artikel |
323 |
Pet imaging of [18]-FDG as a non-invasive indicator of infection versus rejection in lung transplant recipients
|
Jones, H.A |
|
2003 |
22 |
1S |
p. S192- 1 p. |
artikel |
324 |
Plasma neurohormonal expression in LVAD patients: toward hormone-guided therapeutic assessment
|
Thompson, L.O |
|
2003 |
22 |
1S |
p. S195-S196 2 p. |
artikel |
325 |
Poly-ADP-ribose polymerase-inhibition protects against myocardial and endothelial reperfusion injury after heart transplantation
|
Szabo, G. |
|
2003 |
22 |
1S |
p. S143- 1 p. |
artikel |
326 |
Post-operative obesity and cachexia are risk factors for post heart transplant morbidity and mortality: a multi-institutional study of post-operative weight change
|
Grady, K.L |
|
2003 |
22 |
1S |
p. S175- 1 p. |
artikel |
327 |
Preclinical experience in transplant with lung obtained from non heart beating donors
|
Varela, A |
|
2003 |
22 |
1S |
p. S112- 1 p. |
artikel |
328 |
Predicting death following lung transplantation: development of a prognostic model
|
Saeed, I |
|
2003 |
22 |
1S |
p. S93-S94 2 p. |
artikel |
329 |
Prediction of maximal lung function in IPF and COPD single lung transplant recipients
|
Ahmad, S |
|
2003 |
22 |
1S |
p. S194-S195 2 p. |
artikel |
330 |
Predictors and outcomes of acute humoral rejection treated with plasmapheresis in heart transplant recipients
|
Uber, W.E |
|
2003 |
22 |
1S |
p. S169- 1 p. |
artikel |
331 |
Predictors of death on the unos lung transplant waiting list
|
Egan, T |
|
2003 |
22 |
1S |
p. S147- 1 p. |
artikel |
332 |
Predictors of poor RV function following LVAD implantation
|
Boyle, A.J |
|
2003 |
22 |
1S |
p. S205- 1 p. |
artikel |
333 |
Predictors of quality of life at 5 to 6 years after heart transplantation
|
Grady, K.L |
|
2003 |
22 |
1S |
p. S220- 1 p. |
artikel |
334 |
Pre-emptive use of oral valgancyclovir in cardiac recipients
|
Devyatko, E |
|
2003 |
22 |
1S |
p. S123-S124 2 p. |
artikel |
335 |
Pre-existing renal failure doubles 30 day mortality after cardiac transplantation
|
Ostermann, M.E |
|
2003 |
22 |
1S |
p. S209- 1 p. |
artikel |
336 |
Pre-operative predictors of outcome after VAD: can we predict survivors?
|
Harding, J |
|
2003 |
22 |
1S |
p. S205- 1 p. |
artikel |
337 |
Pre-operative renal function and outcomes following orthotopic heart transplantation
|
Odim, J.N.K |
|
2003 |
22 |
1S |
p. S176- 1 p. |
artikel |
338 |
Presence of a positive PRA adversely predicts both short and long term survival following heart transplantation
|
Edwards, B.S |
|
2003 |
22 |
1S |
p. S177-S178 2 p. |
artikel |
339 |
Presence of donor-derived DNA in the plasma of sex-mismatched cardiac transplant recipients: a potential novel strategy for monitoring graft rejection
|
Woo, K.S |
|
2003 |
22 |
1S |
p. S90- 1 p. |
artikel |
340 |
Preservation in microvascular endothelial function despite epicardial endothelial dysfunction in cardiac transplant recipients
|
Kushwaha, S.S |
|
2003 |
22 |
1S |
p. S165-S166 2 p. |
artikel |
341 |
Prevalence of gastro-esophageal reflux disease in lung transplant candidates
|
D’Ovidio, F |
|
2003 |
22 |
1S |
p. S187- 1 p. |
artikel |
342 |
Prevention of bone loss after cardiac transplantation with alendronate or calcitriol: efficacy and safety
|
Maybaum, S |
|
2003 |
22 |
1S |
p. S156- 1 p. |
artikel |
343 |
Prior HLA allosensitization predisposes patients to become and remain highly sensitized after LVAD implantation
|
Drakos, S.G |
|
2003 |
22 |
1S |
p. S205- 1 p. |
artikel |
344 |
Profiling the nonadherent adolescent heart transplant recipient
|
Freeman, M.H |
|
2003 |
22 |
1S |
p. S129- 1 p. |
artikel |
345 |
Prograf decreases plasma cholesterol in heart transplant recipients with treated but persisting mild dyslipidemia: the canadian multicenter randomized trial of prograf versus neoral
|
White, Michel |
|
2003 |
22 |
1S |
p. S140- 1 p. |
artikel |
346 |
Progress towards a more physiologic approach to heart preservation: the advantages of hyperpolarized arrest
|
Diodato, M.D |
|
2003 |
22 |
1S |
p. S103- 1 p. |
artikel |
347 |
Prolonged non-invasive ventilatory support prior to pulmonary transplantation does not affect postoperative outcome
|
Castle, H |
|
2003 |
22 |
1S |
p. S189-S190 2 p. |
artikel |
348 |
Prospective randomized international multi-center investigator driven study comparing TAC and CSA (+MMF/steroids) after lung transplantation - interim analysis of 110 patients
|
Reichenspurner, H |
|
2003 |
22 |
1S |
p. S77- 1 p. |
artikel |
349 |
Prospective short-term pilot study of sirolimus as an induction of immunosuppression in heart transplant recipients
|
Zakliczynski, M |
|
2003 |
22 |
1S |
p. S118- 1 p. |
artikel |
350 |
Protective mechanisms of radical scavengers vitamins C&E in an in-vivo pig model of pulmonary reperfusion injury
|
Wagner, F.M |
|
2003 |
22 |
1S |
p. S188- 1 p. |
artikel |
351 |
Proteonomic analysis of changes in “total” protein expression during bridge to clinical recovery using left ventricular assisst devices (LVADS)
|
Dunn, M.J |
|
2003 |
22 |
1S |
p. S203- 1 p. |
artikel |
352 |
PTLD in a pediatric heart transplant cohort is not associated with traditional risk factors
|
Pahl, E |
|
2003 |
22 |
1S |
p. S134- 1 p. |
artikel |
353 |
PX3.102, a novel immunosuppressant, slows tracheal allograft rejection in the mouse model of obliterative bronchiolitis
|
Chalermskulrat, W |
|
2003 |
22 |
1S |
p. S103- 1 p. |
artikel |
354 |
QTC interval prolongation predicts mortality in patients with transplant coronary artery disease
|
Vrtovec, B |
|
2003 |
22 |
1S |
p. S208- 1 p. |
artikel |
355 |
Quality of life after lung transplantation for lymphangioleiomyomatosis (LAM)
|
Pollock-BarZiv, S.M |
|
2003 |
22 |
1S |
p. S221- 1 p. |
artikel |
356 |
Quality of life and left ventricular assist devices: differences between implanted, explanted and transplanted patients
|
Hallas, C.N |
|
2003 |
22 |
1S |
p. S129- 1 p. |
artikel |
357 |
Rapamycin-based and late FK506-light immunosuppression in heart transplant recipients
|
Griffith, B.P |
|
2003 |
22 |
1S |
p. S118- 1 p. |
artikel |
358 |
Rapamycin (SIROLIMUS) AUC estimation in heart transplant recipients with chronic renal impairment
|
Moloney, E.D |
|
2003 |
22 |
1S |
p. S117-S118 2 p. |
artikel |
359 |
Rapid assessment of quality of life in patients with advanced heart failure
|
Baird, B.L |
|
2003 |
22 |
1S |
p. S132- 1 p. |
artikel |
360 |
Readmission following discharge on LVAD: implications for permanent support
|
Banbury, M.K |
|
2003 |
22 |
1S |
p. S204-S205 2 p. |
artikel |
361 |
Recovery of chronic renal impairment with sirolimus after lung transplantation
|
Venuta, F |
|
2003 |
22 |
1S |
p. S180- 1 p. |
artikel |
362 |
Recovery of right ventricular function post lung transplantation in patients with long-term pulmonary hypertension on contemporary vasodilator therapy
|
Jimenez, J |
|
2003 |
22 |
1S |
p. S191- 1 p. |
artikel |
363 |
Reduced size lung transplantation - follow up on 27 patients
|
Warnecke, G |
|
2003 |
22 |
1S |
p. S189- 1 p. |
artikel |
364 |
Reduction of PECAM-1 at graft endothelium after cardiac transplantation is accompanied by the reduction of leukocyte infiltration into the perivascular space of arteries. a comparative study with CSA, FK506 and MMF
|
Richter, M.H.C |
|
2003 |
22 |
1S |
p. S95- 1 p. |
artikel |
365 |
Rejection with hemodynamic compromise: a dismal prognosis
|
Lee, R |
|
2003 |
22 |
1S |
p. S91- 1 p. |
artikel |
366 |
Relation between quality of life and functional variables in heart transplant recipients
|
Tegtbur, U |
|
2003 |
22 |
1S |
p. S221- 1 p. |
artikel |
367 |
Reliability of the novacor LVAS: implications for destination therapy
|
Livi, U |
|
2003 |
22 |
1S |
p. S196-S197 2 p. |
artikel |
368 |
Renal growth after cardiac transplantation in infants
|
Tsirka, A.E |
|
2003 |
22 |
1S |
p. S135-S136 2 p. |
artikel |
369 |
Reperfusion with blood at 30 deg C improves heart function after myocardial ischemia/reperfusion (I/R) injury. novel mechanism to enhance donor heart
|
Jayakar, D |
|
2003 |
22 |
1S |
p. S113- 1 p. |
artikel |
370 |
Resourse implications of ECMO as a bridge to paediatric heart transplant
|
Whitmore, P |
|
2003 |
22 |
1S |
p. S130- 1 p. |
artikel |
371 |
Risk/benefit-based lung allocation algorithms
|
Murray, S. |
|
2003 |
22 |
1S |
p. S128-S129 2 p. |
artikel |
372 |
Risk factors for death after lung transplant in the US
|
Egan, T. |
|
2003 |
22 |
1S |
p. S146-S147 2 p. |
artikel |
373 |
Role of CMV antigenemia directed preemptive therapy with ganciclovir for the prevention of cmv disease at 6 months in lung transplant recipients
|
Husain, S |
|
2003 |
22 |
1S |
p. S183-S184 2 p. |
artikel |
374 |
Role of interleukin-8 in predicting outcome of donor lungs
|
de Perrot, M |
|
2003 |
22 |
1S |
p. S212- 1 p. |
artikel |
375 |
Role of the ICOS/ICOS ligand costimulating system in endothelial cell-dependent T cell activation
|
Klingenberg, R |
|
2003 |
22 |
1S |
p. S155-S156 2 p. |
artikel |
376 |
Role of the thymus in heterotopic cardiac allograft survival in miniature swine: evidence for the need of thymic emigrants immediately post-transplantation, and thymic immigrants for long term tolerance induction
|
Yamamoto, S |
|
2003 |
22 |
1S |
p. S162- 1 p. |
artikel |
377 |
Routine cytopathology testing is unnecessary with bronchoscopy following lung transplantation
|
Wanner, T.J |
|
2003 |
22 |
1S |
p. S181-S182 2 p. |
artikel |
378 |
Scientific program
|
|
|
2003 |
22 |
1S |
p. S23-S73 51 p. |
artikel |
379 |
Scientific program committee
|
|
|
2003 |
22 |
1S |
p. S2- 1 p. |
artikel |
380 |
Scoring of 2,788 endomyocardial biopsies correlate rejection to the development of transplant coronary artery disease after heart transplantation
|
Espejo Vassilakis, M. |
|
2003 |
22 |
1S |
p. S139- 1 p. |
artikel |
381 |
Scoring system determines successful RVAD explant following BiVAD support: implications for destination therapy
|
Patel, H.J |
|
2003 |
22 |
1S |
p. S84- 1 p. |
artikel |
382 |
Screening potential donors for living donor lobar lung transplantation
|
Schenkel, F.A |
|
2003 |
22 |
1S |
p. S86-S87 2 p. |
artikel |
383 |
Screening scale for predicting outcomes in high-risk potential heart transplant candidates under extracorporeral membrane oxygenation
|
Chen, Y.S |
|
2003 |
22 |
1S |
p. S200-S201 2 p. |
artikel |
384 |
Sequential expression of three known protective genes in cardiac biopsies after transplantation
|
De Souza, A.I |
|
2003 |
22 |
1S |
p. S163- 1 p. |
artikel |
385 |
Serial echocardiography increases donor heart utilization
|
Babcock, W.D |
|
2003 |
22 |
1S |
p. S74- 1 p. |
artikel |
386 |
Serious abdominal complications of intra-peritoneal placement of left ventricular assist devices
|
Tansley, P |
|
2003 |
22 |
1S |
p. S202- 1 p. |
artikel |
387 |
Short and long term outcomes using marginal pulmonary allograft donors
|
Luckraz, H |
|
2003 |
22 |
1S |
p. S116- 1 p. |
artikel |
388 |
Should we transplant UNOS status 2 patients?
|
Jimenez, J. |
|
2003 |
22 |
1S |
p. S146- 1 p. |
artikel |
389 |
Significant reduction in major LVAD device failures: comparison of the heartmate® VE and XVE LVAS
|
Pagani, F.D |
|
2003 |
22 |
1S |
p. S204- 1 p. |
artikel |
390 |
Simvastatin restores contractile function and reduces cardiac remodeling in cardiomyopathy
|
Osorio, J.C |
|
2003 |
22 |
1S |
p. S107-S108 2 p. |
artikel |
391 |
Single cell detection of IFN-gamma production identifies lung recipients at high risk for early immune complications
|
Mohler, K |
|
2003 |
22 |
1S |
p. S99- 1 p. |
artikel |
392 |
Single center comparison of pediatric living donor lobar and cadaveric lung transplant
|
Sweet, S.C. |
|
2003 |
22 |
1S |
p. S145-S146 2 p. |
artikel |
393 |
Sirolimus in combination with tacrolimus for primary immunosuppression after orthotopic heart transplantation
|
Mueller, M |
|
2003 |
22 |
1S |
p. S118-S119 2 p. |
artikel |
394 |
Site of heterotopic tracheal allograft implantation affects graft rejection pattern
|
Sadegh Beigi, F |
|
2003 |
22 |
1S |
p. S104- 1 p. |
artikel |
395 |
Sodium-hydrogen exchanger inhibition is superior to pharmacological preconditioning for extended cardiac allograft preservation
|
Ryan, J.B |
|
2003 |
22 |
1S |
p. S113- 1 p. |
artikel |
396 |
Specific dysregulation of troponins and inflammatory marker genes in endomyocardial biopsies from heart transplant recipients
|
Kelemen, S.E |
|
2003 |
22 |
1S |
p. S99- 1 p. |
artikel |
397 |
Specific gene expression profile associated with ischemia-reperfusion injury during lung transplantation identified by CDNA microarray
|
Yamane, M |
|
2003 |
22 |
1S |
p. S187- 1 p. |
artikel |
398 |
Stable left ventricular volumes and function following Dor ventriculoplasty
|
Patel, H.J |
|
2003 |
22 |
1S |
p. S157-S158 2 p. |
artikel |
399 |
Statin treatment decreases QTC interval duration and improves survival in heart transplant recipients
|
Vrtovec, B |
|
2003 |
22 |
1S |
p. S174- 1 p. |
artikel |
400 |
Stem cells mobilization treatment removing severe congestive heart failure patients from heart transplantation indication- preliminary results
|
Bocchi, E.A |
|
2003 |
22 |
1S |
p. S124- 1 p. |
artikel |
401 |
Study of the safety and tolerability of Simulect® (basiliximab) versus OKT3 in heart transplantation
|
Crespo-Leiro, M.G. |
|
2003 |
22 |
1S |
p. S141- 1 p. |
artikel |
402 |
Sublingual sildenafil and reversibility of pulmonary hypertension in candidates to heart transplant
|
Gomez Sanchez, M.A |
|
2003 |
22 |
1S |
p. S86- 1 p. |
artikel |
403 |
Successful outcome in lung transplant recipients who receive organs from donors with rapid onset fatal asthma
|
Hopkins, P.M.A |
|
2003 |
22 |
1S |
p. S112- 1 p. |
artikel |
404 |
Supporters
|
|
|
2003 |
22 |
1S |
p. S13- 1 p. |
artikel |
405 |
Surgical risk factor analysis in lung transplantation
|
Muller, L.C |
|
2003 |
22 |
1S |
p. S193- 1 p. |
artikel |
406 |
Surveillance Bronchoscopy (SB) in Lung Transplant Recipients (LTR): risk versus benefit?
|
McWilliams, T.J |
|
2003 |
22 |
1S |
p. S190- 1 p. |
artikel |
407 |
Survival benefit of heart transplantation in high risk donors and recipients
|
Luckraz, H |
|
2003 |
22 |
1S |
p. S163-S164 2 p. |
artikel |
408 |
Survival benefit of lung transplantation in cystic fibrosis patients infected with B. Cepacia
|
Gutierrez, C.A |
|
2003 |
22 |
1S |
p. S93- 1 p. |
artikel |
409 |
Survival of lung transplant recipients with bronchiolitis obliterans syndrome
|
Valentine, V.G |
|
2003 |
22 |
1S |
p. S193-S194 2 p. |
artikel |
410 |
Survival of lung transplant recipients with Cystic Fibrosis (CF) harboring panresistant bacteria other than B. cepacia, compared to patients harboring sensitive bacteria
|
Hadjiliadis, D |
|
2003 |
22 |
1S |
p. S190-S191 2 p. |
artikel |
411 |
Switch from euro-collins® to perfadex® for pulmonary graft preservation resulted in superior outcome in transplant recipients
|
Rega, F |
|
2003 |
22 |
1S |
p. S111- 1 p. |
artikel |
412 |
Tacrolimus in heart transplantation: monotherapy vs. steroid requiring patients
|
Galin, I.D |
|
2003 |
22 |
1S |
p. S150- 1 p. |
artikel |
413 |
Tacrolimus: in vitro effects on neutrophil production and apoptosis
|
Koenig, J.M |
|
2003 |
22 |
1S |
p. S96- 1 p. |
artikel |
414 |
Temporal alteration in B-type natriuretic peptide expression predicts allograft failure in heart transplantation
|
Park, M.H |
|
2003 |
22 |
1S |
p. S156-S157 2 p. |
artikel |
415 |
Ten year experience with human lung transplantation from non-heart beating donors
|
Love, R.B |
|
2003 |
22 |
1S |
p. S87- 1 p. |
artikel |
416 |
Ten year follow-up of recipients of a kidney or heart transplant who received induction therapy with a monoclonal antibody against the interleukin-2 receptor
|
Wabbijn, M |
|
2003 |
22 |
1S |
p. S121-S122 2 p. |
artikel |
417 |
The change of ultrasonic tissue characterization with integrated backscatter is a significant marker to diagnose cardiac allograft vasculopathy
|
Nunoda, S |
|
2003 |
22 |
1S |
p. S170- 1 p. |
artikel |
418 |
The contribution of blood product transfusions to HLA allosensitization in LVAD recipients
|
Drakos, S.G |
|
2003 |
22 |
1S |
p. S197-S198 2 p. |
artikel |
419 |
The differences in hemodyanamics, cardiac function and myocardial structure associated with chronic mechanical circulatory in patients support with either pulsatile or continuous flow left ventricular assist devices
|
Thohan, V |
|
2003 |
22 |
1S |
p. S219- 1 p. |
artikel |
420 |
The differential impact of spironolactone on patterns of pro-inflammatory cytokine expression in advanced heart failure
|
Becker, J.R |
|
2003 |
22 |
1S |
p. S108- 1 p. |
artikel |
421 |
The direct and indirect allogeneic presentation pathway during acute rejection after human cardiac transplantation
|
van Besouw, N.M |
|
2003 |
22 |
1S |
p. S167-S168 2 p. |
artikel |
422 |
The effect of oversizing cardiac allografts on survival in pediatric patients with congenital heart disease
|
Razzouk, A.J. |
|
2003 |
22 |
1S |
p. S145- 1 p. |
artikel |
423 |
The effect on microvascular function of combined mechanical circulatory support and pharmacological therapy during induction of myocardial recovery
|
Tansley, P |
|
2003 |
22 |
1S |
p. S196- 1 p. |
artikel |
424 |
The efficacy of partial liquid ventilation on lung protection during hypotension and cardiac arrest
|
Sekine, Y |
|
2003 |
22 |
1S |
p. S114- 1 p. |
artikel |
425 |
The hub-and-spoke sysytem in treating acute cardiogenic shock: who survives?
|
Kherani, A.R |
|
2003 |
22 |
1S |
p. S198- 1 p. |
artikel |
426 |
The impact of a positive donor-specific crossmatch on outcome after heart transplantion
|
Schmitz, S.S |
|
2003 |
22 |
1S |
p. S91-S92 2 p. |
artikel |
427 |
The impact of induction therapy and the donor specific crossmatch on outcome after heart transplantation
|
Devyatko, E |
|
2003 |
22 |
1S |
p. S169- 1 p. |
artikel |
428 |
The impact of pharmacogenomic factors on steroid weaning in pediatric heart transplant patients using logistic regression analysis
|
Zheng, H.X. |
|
2003 |
22 |
1S |
p. S141- 1 p. |
artikel |
429 |
The intrinsic mitochondrial oxidative capacity of the failing heart is depressed and relates to markers of disease severity
|
Mettauer, B |
|
2003 |
22 |
1S |
p. S108- 1 p. |
artikel |
430 |
The Micromed-Debakey VAD: initial american experience
|
Goldstein, D.J |
|
2003 |
22 |
1S |
p. S218- 1 p. |
artikel |
431 |
The predictive value of bronchiolitis obliterans syndrome stage 0-p
|
Hachem, R.R |
|
2003 |
22 |
1S |
p. S78- 1 p. |
artikel |
432 |
The prostacycline derivative “ILOPROST” as an additive to low potassium dextran (LPD) preservation solution improves early graft function following porcine lung transplantation after 24 hours of cold ischemia
|
Gohrbandt, B |
|
2003 |
22 |
1S |
p. S110-S111 2 p. |
artikel |
433 |
Therapy of erectile dysfunction by sildenafil (viagra) in patients after orthotopic heart transplantation
|
Deyerling, K.W |
|
2003 |
22 |
1S |
p. S166- 1 p. |
artikel |
434 |
Therapy with prostanoids and transplantation in patients with primary pulmonary hypertension
|
Dandel, M |
|
2003 |
22 |
1S |
p. S184- 1 p. |
artikel |
435 |
The right ventricular response to pulmonary hypertension is related to left ventricular mass
|
Saba, T |
|
2003 |
22 |
1S |
p. S179-S180 2 p. |
artikel |
436 |
The risk of bronchiolitis obliterans syndrome is reduced in lung transplant patients who receive mycophenolate mofetil based immunosuppression
|
Dunitz, J.M |
|
2003 |
22 |
1S |
p. S151- 1 p. |
artikel |
437 |
The risk of thromboembolism with the novacor left ventricular assist device
|
Rogers, J.G |
|
2003 |
22 |
1S |
p. S202- 1 p. |
artikel |
438 |
The risk of transmission of hepatitis B from from donors with hepatitis B core antibody positivity is low
|
Pinney, S.P |
|
2003 |
22 |
1S |
p. S213- 1 p. |
artikel |
439 |
The role of epithelial cell apoptosis in allograft transplant-induced airway obliteration
|
Segall, L.E |
|
2003 |
22 |
1S |
p. S99-S100 2 p. |
artikel |
440 |
The role of poly(ADP)ribose synthetase in lung ischemia-reperfusion injury
|
Woolley, S.M. |
|
2003 |
22 |
1S |
p. S142-S143 2 p. |
artikel |
441 |
The safety and efficacy of bosentan in pulmonary hypertension due to congenital heart disease
|
Benza, R.L |
|
2003 |
22 |
1S |
p. S152- 1 p. |
artikel |
442 |
The tolerability and efficacy of total lymphoid irradiation (TLI) in the control of rapidly progressive bronchiolitis obliterans syndrome
|
Fisher, A.J |
|
2003 |
22 |
1S |
p. S151-S152 2 p. |
artikel |
443 |
The use of bosentan and a prostacyclin analog in the treatment of primary pulmonary hypertension
|
Rayburn, B.K |
|
2003 |
22 |
1S |
p. S152- 1 p. |
artikel |
444 |
The utility of CMV hyper immunoglobulin in the treatment of CMV mismatch lung transplant recipients
|
Malouf, M.A |
|
2003 |
22 |
1S |
p. S191-S192 2 p. |
artikel |
445 |
Time course of physical reconditioning during exercise rehabilitation late after heart transplantation
|
Tegtbur, U |
|
2003 |
22 |
1S |
p. S216- 1 p. |
artikel |
446 |
Time-dependent mortality risk of heart transplantation compared with remaining on the waitlist
|
Merion, R.M |
|
2003 |
22 |
1S |
p. S147- 1 p. |
artikel |
447 |
Time-dependent mortality risk of lung transplantation compared with remaining on the waitlist
|
McCullough, K.P. |
|
2003 |
22 |
1S |
p. S146- 1 p. |
artikel |
448 |
Tissue doppler echocardiography - new insights into cardiac allograft function in children
|
Pauliks, L.B |
|
2003 |
22 |
1S |
p. S214- 1 p. |
artikel |
449 |
Tissue doppler echocardiography predicts positive left ventricular remodeling after biventricular pacing in severe heart failure
|
Penicka, M |
|
2003 |
22 |
1S |
p. S159- 1 p. |
artikel |
450 |
To induce or not to induce: current assessment of perioperative immunosuppression practices and outcome in heart transplantation
|
Higgins, R |
|
2003 |
22 |
1S |
p. S176- 1 p. |
artikel |
451 |
Tolerability of carvedilol in children with severe heart failure referred to a transplantation centre
|
Ford, K.A |
|
2003 |
22 |
1S |
p. S135- 1 p. |
artikel |
452 |
Total artificial heart bridge to transplantation: a 9 year experience in 61 patients
|
Copeland, J.G |
|
2003 |
22 |
1S |
p. S148- 1 p. |
artikel |
453 |
Transcriptional profiling of the vascular smooth muscle cell response to allograft injury
|
Absaieri, M.V |
|
2003 |
22 |
1S |
p. S101- 1 p. |
artikel |
454 |
Transplantation of a mixed population of bone marrow-derived progenitor cells improves regional systolic function in a rabbit model of cryoinjured myocardium
|
Thompson, R.B |
|
2003 |
22 |
1S |
p. S80- 1 p. |
artikel |
455 |
Transplantation using hearts from primary pulmonary hypertensive donors for recipients with high pulmonary vascular resistance
|
Birks, E.J |
|
2003 |
22 |
1S |
p. S156- 1 p. |
artikel |
456 |
Tricuspid regurgitation after cardiac transplantation: how many biopsies are too many?
|
Nguyen, V |
|
2003 |
22 |
1S |
p. S171-S172 2 p. |
artikel |
457 |
Two-year experience with continuous subcutaneous treprostinil (prostacyclin stable analogue) in severe pulmonary hypertension treatment
|
Ruiz-Cano, M.J |
|
2003 |
22 |
1S |
p. S180- 1 p. |
artikel |
458 |
Unexpected role for HO-1 in the clinical heart transplant setting
|
Holweg, C |
|
2003 |
22 |
1S |
p. S164- 1 p. |
artikel |
459 |
Utility of B-type natriuretic peptide in cardiac transplant evaluation
|
Bhat, G |
|
2003 |
22 |
1S |
p. S174- 1 p. |
artikel |
460 |
Utility of neurohumoral profiles in pulmonary hypertension: clinical and hemodynamic correlations
|
Frantz, R.P |
|
2003 |
22 |
1S |
p. S153-S154 2 p. |
artikel |
461 |
Utility of the natriuretic peptides, ANP and BNP in the diagnosis of impaired cardiac function in organ donors
|
Nyawo, B |
|
2003 |
22 |
1S |
p. S115-S116 2 p. |
artikel |
462 |
Vascular endothelial growth factor gene polymorphism are associated with acute rejection after heart transplantation
|
Datta, S |
|
2003 |
22 |
1S |
p. S163- 1 p. |
artikel |
463 |
Vascularized thymic lobe transplantation: experience with an allogeneic and xenogeneic large animal model of transplantation
|
Vagefi, P.A |
|
2003 |
22 |
1S |
p. S89- 1 p. |
artikel |
464 |
Vascular thrombosis in patients with long term Jarvik 2000 VAD support
|
Delgado, R.M |
|
2003 |
22 |
1S |
p. S218- 1 p. |
artikel |
465 |
Visualization of alloreactive CD4 T cell responses and tolerance induction in vivo
|
Sandner, S |
|
2003 |
22 |
1S |
p. S161-S162 2 p. |
artikel |
466 |
What contributes to emotional distress in female heart transplant recipients?
|
Gerard, I |
|
2003 |
22 |
1S |
p. S131-S132 2 p. |
artikel |
467 |
Which heart transplant recipients are likely to survive more than 10 years?
|
Segovia, J |
|
2003 |
22 |
1S |
p. S166- 1 p. |
artikel |
468 |
Yield of surveillance and diagnostic transbronchial lung biopsies (TBB) performed beyond one year after lung transplantation
|
Wennström, R. |
|
2003 |
22 |
1S |
p. S139- 1 p. |
artikel |